NG2X Pharma ApS

CVR 46229355 · Private limited company (ApS) · Active · Medium risk

NG2X Pharma ApS is a Private limited company (ApS), founded on , based in Ringsted. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. CEO: Nicolaj Donskov Nielsen.

Bankruptcy risk for NG2X Pharma ApS

1.6%
probability of bankruptcy within 12 months
Medium risk

1.1 × the average (1.41%) · higher risk than 79% of active Danish companies

Lowest riskHighest risk

Increases the risk

Published annual reports0 · bankruptcy rate 16.7%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Time since new CEO0.5–1 yrs · bankruptcy rate 15.6%1.8×
Age (years)< 1 yrs · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

CEO's other companies1 · bankruptcy rate 7.3%0.83×
Moves in the last 2 years0 · bankruptcy rate 7.4%0.84×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
46229355
Status
Active
Company type
Private limited company (ApS)
Founded
(0 years)
Address
Vermehrensvej 8
4100 Ringsted
Municipality
Ringsted
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 20k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 0
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Management, owners and auditor

RoleNameFromTo
CEONicolaj Donskov NielsenCurrent
Owner (100%)VILAS PHARMACEUTICAL SERVICES ApSCurrent
FounderVILAS PHARMACEUTICAL SERVICES ApSCurrent

The CEOs' other companies

Nicolaj Donskov Nielsen – 1 other companies

Address history (0 moves)

Vermehrensvej 8, 4100 Ringsted

Other companies at the same address

Similar companies in Ringsted

Questions and answers about NG2X Pharma ApS

Has NG2X Pharma ApS gone bankrupt?

No, NG2X Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of NG2X Pharma ApS?

Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.

Who is the CEO of NG2X Pharma ApS?

Nicolaj Donskov Nielsen is the CEO of NG2X Pharma ApS.

When was NG2X Pharma ApS founded?

NG2X Pharma ApS was founded on 29 January 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.